Aerie Pharmaceuticals is a pharmaceutical company specializing in ophthalmology, particularly glaucoma and other eye diseases. Aerie Pharmaceuticals develop and commercialize therapies, with products like Rhopressa and Rocklatan, which are FDA-approved for reducing intraocular pressure. Aerie was acquired by Alcon in 2022.